Chongqing Enlian Biotechnology Co., Ltd

COMPANY PROFILE Chongqing Enlian Biotechnology Co., Ltd. located in Chongqing Changshou Economic and Technological Development Zone, a national pharmaceutical and chemical industrial Park, is a high-tech enterprise integrating R&D, production, and sales. The company was established in July 2019 with a registered capital of 5 million RMB. In 2023, the output value reached 50 million RMB, and it is expected that the output value will reach 80 million RMB in 2024. Focusing on research and development and production, the company holds two sales subsidiaries--Enlian biological medicine (Chongqing) Co.,Ltd.--oriented towards the sales of pharmaceutical intermediates, and Chongqing Xingenlian Pharmaceutical Co., Ltd.--focused on the direction of new materials/daily chemicals/food additives. Our clients mainly include domestic pharmaceutical listed companies and large chemical sales companies (export-oriented). Main Business Custom research and development/production and sales of pharmaceuticals, new materials, daily chemical intermediates and food/pharmaceutical grade auxiliaries. Process optimization and technical services for pharmaceutical intermediates/APIs/material intermediates. Custom synthesis of impurity reference standards/API working reference standards/new compounds.